Senisca
Developer of senotherapeutics that targets the diseases and signs of ageing. The company develops a new generation of oligonucleotide-based therapies that helps in reversing the aging of old cells and tissues through modulation of RNA splicing. This helps in the restoration of splicing factor levels and reverse senescence. The company was founded in 2020 and headquartered in Exeter, United Kingdom. It has raised $9M…
Funding snapshot
About
Developer of senotherapeutics that targets the diseases and signs of ageing. The company develops a new generation of oligonucleotide-based therapies that helps in reversing the aging of old cells and tissues through modulation of RNA splicing. This helps in the restoration of splicing factor levels and reverse senescence. The company was founded in 2020 and headquartered in Exeter, United Kingdom. It has raised $9M in series a funding, with backing from Emerging Longevity Ventures, QantX, R42 Group, Trend Investment Group, and others. The company operates in the Life Sciences - Genomics, Life Sciences - Gene Therapy space. The company leverages advanced technology to deliver innovative solutions tailored to its target market, addressing key industry challenges and driving value for its customers.
Business model
Genomics > Applied Genomics > Clinical Genomics > Therapeutics
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.